about
Retrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women?Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis CSafety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled TrialsHepatocellular carcinoma and the risk of occupational exposureRecent advances in managing chronic HCV infection: focus on therapy in patients with severe liver diseaseType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightHepatitis C virus relies on lipoproteins for its life cycleHistorical review of the causes of cancerHepatitis C virus: A time for decisions. Who should be treated and when?Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent dataAlcohol and Viral Hepatitis: Role of Lipid RaftsStatus of hepatitis C virus vaccination: Recent updateChronic hepatitis C: This and the new era of treatmentThe Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-AnalysisGenetic, metabolic and environmental factors involved in the development of liver cirrhosis in MexicoInterferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV InfectionA New Twist to a Chronic HCV Infection: Occult Hepatitis CChronic hepatitis C: future treatmentHepatitis C virus: A global viewDirect effects of hepatitis C virus on the lymphoid cellsHepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion.HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, ChinaAge and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central ChinaAntibodies to the Novel Human Pegivirus 2 Are Associated with Active and Resolved InfectionsMouse Systems to Model Hepatitis C Virus Treatment and Associated ResistanceSpecific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitisDirect-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney diseaseRIG-I in RNA virus recognitionHepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlHepatitis C.Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testingLimiting the access to direct-acting antivirals against HCV: an ethical dilemma.Inactivation of HCV and HIV by microwave: a novel approach for prevention of virus transmission among people who inject drugsGeographic integration of hepatitis C virus: A global threat.Serum aminotransferase ratio is independently correlated with hepatosteatosis in patients with HCV: a cross-sectional observational study.Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.Incidence of HCV induced-Esophageal varices in Egypt: Valuable knowledge using data mining analysisPrevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, RwandaEstimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
P2860
Q24658656-D38A1F50-8E25-4ED0-AB34-7311BCCADC50Q26741123-216B5D49-FEB3-494F-AE4A-77ACFCC9AE5FQ26745895-C5EAD243-0300-4805-9AE8-D12AFE09690EQ26750646-3D839327-1CE4-4B8A-8714-F6D22D344AEBQ26752433-AEE6BF2B-7E26-479D-AE8E-18E58DFCFD43Q26752583-F1BB5FAF-3E2A-4F50-923D-075FCF905F44Q26766119-F3AD4025-1667-48B6-ACE5-6832397F9255Q26767036-61211688-F5EC-4E3B-AF72-B8E01D5AB464Q26768274-1E2D1147-A584-4CFC-98C5-D62FC4C39FB9Q26773191-A23D442B-D794-4E5C-801C-9D7436249D3AQ26773213-97C8AE57-1C4E-42EC-AD64-C8FAE4436046Q26774612-C79BE957-0589-4DB9-A10E-94C5092F52B7Q26775011-1675EB1C-5817-4967-8E3D-CF1E41843E26Q26777560-4F7539AC-62F5-4239-AB3E-70F7283238F1Q26778035-29C5FDEA-EE9A-4DF6-BE3E-5DD66908F29DQ26784252-73EAD9B3-DF5D-4ED7-A08E-7A2D58B876C1Q26798189-08247DCF-E106-4A2E-8EEA-610FF7E0479BQ26824075-BC8CEBEA-E5E2-41B3-B76E-3D60052D8CDBQ26862531-5BAF56FC-1F44-46F2-91EB-E839AAB24899Q26992142-6460B124-2424-49CD-8A13-1EEC258E8E66Q27321791-C2D93AB8-4870-4236-85A8-F157BC9AFDF1Q27468608-2A82C303-A3A0-439B-8F35-0B02D843447AQ27468718-2BC6D3AE-342C-4D65-B6D8-66454660CADCQ27468921-15C3D24A-81FE-48F0-93AF-7B2BD2FDC0C4Q27469038-37C0D1BA-B66D-46F5-AF0C-25F64DF0023EQ28074434-298A8D4B-F209-4E80-8F9A-721DB3B21CF7Q28077263-38C2C58C-D409-48DD-A2A3-F04FAB8EBBFEQ28081618-81313510-B817-4371-A408-EAD7F1D64F25Q28082128-6ED01028-8A0E-48D4-B352-A95F4F0815B8Q28084654-CAE10E73-4336-47D2-9505-F4CA5B532EA4Q28545237-6FE42D22-4B69-400A-A44E-DD51854E701EQ30244361-0500C5F8-EB74-4948-A387-688A8BFDB8B8Q30369227-F635A880-86C7-4E57-8269-58B3A75FC48FQ30395543-C5C5C392-923E-4A79-8D1E-5FDD02F14EEAQ30401616-F9296038-939D-42F9-A48B-49AFC8F1DF77Q30881190-FA9F358B-28FC-427A-AB6D-77DF7564F795Q31156692-B0BB9BA1-160A-4B00-B5F1-D65AD02E15CBQ33439743-FE8A6028-ED56-4687-828C-7763FCBFFFDEQ33629597-77AF7B81-1395-434D-AADD-67BDBC3405B4Q33643082-AD87E4A2-2FEA-4947-B5C6-105C9EC2E887
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidemiology and natural history of HCV infection.
@en
type
label
Epidemiology and natural history of HCV infection.
@en
prefLabel
Epidemiology and natural history of HCV infection.
@en
P1476
Epidemiology and natural history of HCV infection
@en
P2093
Gregory J Dore
Jason Grebely
P2888
P304
P356
10.1038/NRGASTRO.2013.107
P407
P577
2013-07-02T00:00:00Z